Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 2016-2019

  Anderson, C P ^a   Tsai, J ^a   Chan, W ^a   Park, C K ^a   Tian, L ^b   Lui, R M ^b   Forman, H J ^b   Reynolds, C P ^b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alkylator resistance; BSO; Buthionine sulfoximine; Glutathione; L PAM; Melphalan; Neuroblastoma

Indexed keywords

BUTHIONINE SULFOXIMINE; MELPHALAN;

ALKYLATION; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CELL KILLING; CONFERENCE PAPER; CYTOFLUOROMETRY; CYTOTOXICITY; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IONIZING RADIATION; NEUROBLASTOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; BUTHIONINE SULFOXIMINE; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; GLUTATHIONE; HUMANS; MELPHALAN; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0031427398     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00203-7     Document Type: Conference Paper

References (30)

1. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313, 1111-1116.
2. Reynolds CP, Seeger RC. Neuroblastoma. In Haskell CM, ed. Cancer Treatment. Philadelphia, PA, W. B. Saunders, 1995, 860-871.
3. Tew KD, Houghton PJ, Houghton JA. Modulation of glutathione. In Tew KD, Houghton PJ, Houghton JA, eds. Preclinical and Clinical Modulation of Anticancer Drugs. Boca Raton, Florida, CRC Press, 1993, 13-77.
4. Biaglow J. E., Varnes M. E., Clark E. P., Epp E. R. The role of thiols in cellular response to radiation and drugs. Radiat Res. 95:1983;437-455.
5. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983, 52, 711-760.
6. Samuels B. L., Bitran J. D. High-dose intravenous melphalan: a review. J Clin Oncol. 13:1995;1786-1799.
7. Arrick B. A., Nathan C. F. Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res. 44:1984;4224-4232.
8. Russo A., DeGraff W., Friedman N., Mitchell J. B. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res. 46:1986;2845-2848.
9. Hamilton TC, Winker MA, Louie KG, et al. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol 1985, 34, 2583-2586.
10. Meister A., Griffith O. W. Effects of methionine sulfoximine analogs on the synthesis of glutamine and glutathione: possible chemotherapeutic implications. Cancer Treat Rep. 63:1978;1115-1121.
11. Green J. A., Vistica D. T., Young R. C., et al. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res. 44:1984;5427-5431.
12. Ozols RF, Louie KG, Plowman J, et al. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharmacol 1987, 36, 147-153.
13. Siemann D. W., Beyers K. L. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy. Br J Cancer. 68:1993;1071-1079.
14. Jordan J., dArcy Doherty M., Cohen G. M. Effects of glutathione depletion on the cytotoxicity of agents toward a human colonic tumour cell line. Br J Cancer. 55:1987;627-631.
15. Prezioso J. A., Fitzgerald G. B., Wick M. M. Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells. Pigment Cell Res. 3:1990;49-54.
16. Kable E. P., Favier D., Parsons P. G. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine. Cancer Res. 49:1989;2327-2331.
17. Somfai Relle S., Suzukake K., Vistica B. P., Vistica D. T. Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard. Biochem Pharmacol. 33:1984;485-490.
18. Skapek SX, VanDellen AF, McMahon DP, et al. Melphalan-induced toxicity in nude mice following pretreatment with buthionine sulfoximine. Cancer Chemother Pharmacol 1991, 28, 15-21.
19. Bailey HH, Mulcahy RT, Tutsch KD, et al. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J Clin Oncol 1994, 12, 194-205.
20. O'Dwyer PJ, Hamilton TC, Young RC, et al. Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results. J Natl Cancer Inst 1992, 84, 264-267.
21. Yao K., Godwin A. K., Ozols R. F., Hamilton T. C., O'Dwyer P. J. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment. Cancer Res. 53:1993;3662-3666.
22. Ripple GH, Mulcahy RT, Tutsch KD, et al. Tumor glutathione (GSH) depletion to <10% of baseline observed during a phase I trial of continuous infusion (CI) L-S, R-buthionine sulfoximine (BSO). Am Assoc Cancer Res 1995, 36, 238.
23. Reynolds CP, Brodeur GM, Tomayko MM, et al. Biological classification of cell lines derived from human extra-cranial neural tumors. Prog Clin Biol Res 1988, 271, 291-306.
24. Proffitt R. T., Tran J. V., Reynolds C. P. A fluorescence digital image microscopy system for quantifying relative cell numbers in tissue culture plates. Cytometry. 24:1996;204-213.
25. ™, 1988 (Diskette).
26. ApopTag: In Situ Apoptosis Detection Kit - Fluorescein. Gaithersburg, Maryland, Oncor Inc., 1995, 1-28.
27. Hissin P. J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem. 74:1976;214-226.
28. Colvin O. M., Friedman H. S., Gamcsik M. P., Fenselau C., Hilton J. Role of glutathione in cellular resistance to alkylating agents. Adv Enzyme Regul. 33:1993;19-26.
29. Cameron R., Kellen J., Kolin A., Malkin A., Farber E. Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis. Cancer Res. 38:1978;823-829.
30. Reynolds C. P., Perez-Polo J. R. Ascorbic acid enhances the cytotoxic effect of 6-hydroxydopamine for human neuroblastoma cell lines. Neurosci Lett. 26:1981;151-155.